Target intelligence / Profile preview

Transmembrane protein 223 (TMEM223)

Target
TMEM223
Molecular classification
Integral membrane protein, Mitochondrial inner membrane protein, TMEM70/TMEM186/TMEM223 protein family
01

Overview

Transmembrane protein 223 (TMEM223) is a conserved, integral membrane protein localized to the mitochondrial inner membrane, with its N- and C-termini exposed to the matrix. It is a member of the TMEM70/TMEM186/TMEM223 protein family and functions as a mitochondrial ribosome-associated factor essential for the early steps of cytochrome c oxidase (complex IV) assembly. TMEM223 stimulates the translation of mitochondrial-encoded COX1 mRNA and is a constituent of early COX1 assembly intermediates. Loss of TMEM223 in human cells impairs cytochrome c oxidase activity by reducing COX1 synthesis but does not entirely abolish complex IV assembly, suggesting partial redundancy with other assembly factors. TMEM223 is not known to act as a classical therapeutic target (receptor, transporter, enzyme), and there are no reported direct drug interactions or clinical biomarker applications.

Other names
TMEM223Transmembrane protein 223MGC3196Mrx15TM223 (UniProt recommended symbol)HGNC:28464
02

Mechanism of action

Not applicable (no drugs target this protein directly; it acts as a biogenesis/assembly factor for complex IV of mitochondrial OXPHOS)

03

Biological functions

Mitochondrial ribosome bindingEarly assembly of cytochrome c oxidase (complex IV)Stimulation of mitochondrial-encoded COX1 (MT-CO1) translationConstituent of early COX1 assembly intermediates
04

Disease associations

Other/Unclear (No established links to specific human diseases as of current evidence; essential for mitochondrial respiratory function)
05

Safety considerations

None reported (no established safety issues regarding TMEM223 as a therapeutic target or biomarker; loss of function impairs mitochondrial complex IV but no targeted therapeutics exist)
06

Interacting drugs

None known (no drugs have been reported to interact with or target TMEM223)
07

Biomarkers

None reported (TMEM223 is not in clinical use as a biomarker)

Beyond the preview

Go deeper on Transmembrane protein 223 (TMEM223).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 223 (TMEM223).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call